Lukas Mach

11PUBLICATIONS
38CO-AUTHORS
Biologically active moleculesMicroelectronicsMedical molecular engineering of nucleic acids and proteinsChemical engineering designGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 05, 2023
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.

Shiva Izadi, Simon Gumpelmair, Pedro Coelho

|Dec 24, 2022
Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Rong Zhu, Daniel Canena, Mateusz Sikora

|Jan 25, 2022
Designed SARS-CoV-2 receptor binding domain variants form stable monomers.

Miriam Klausberger, Nikolaus F Kienzl, Gerhard Stadlmayr

|Dec 20, 2021
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.

Tümay Capraz, Nikolaus F Kienzl, Elisabeth Laurent

|Aug 10, 2021
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.

David Hoffmann, Stefan Mereiter, Yoo Jin Oh

|Jan 22, 2021
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana.

Alexandra Castilho, Jennifer Schwestka, Nikolaus F Kienzl

Pageof 2

Frequent Collaborators

5 joint publications

Nikolaus F Kienzl

4 joint publications

Josef M Penninger

4 joint publications

Elisabeth Laurent

4 joint publications

Miriam Klausberger